nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—SLCO1A2—Rifampicin—leprosy	0.109	0.116	CbGbCtD
Nelfinavir—SLCO1B1—Rifampicin—leprosy	0.103	0.109	CbGbCtD
Nelfinavir—CYP3A7—Rifampicin—leprosy	0.0602	0.0642	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0602	0.0642	CbGbCtD
Nelfinavir—CYP2B6—Rifampicin—leprosy	0.0573	0.0611	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0497	0.053	CbGbCtD
Nelfinavir—CYP3A7—Dapsone—leprosy	0.0497	0.053	CbGbCtD
Nelfinavir—CYP3A5—Thalidomide—leprosy	0.0466	0.0497	CbGbCtD
Nelfinavir—CYP3A5—Rifampicin—leprosy	0.0451	0.0481	CbGbCtD
Nelfinavir—CYP2C19—Thalidomide—leprosy	0.0376	0.0401	CbGbCtD
Nelfinavir—CYP3A5—Dapsone—leprosy	0.0373	0.0397	CbGbCtD
Nelfinavir—CYP2C19—Rifampicin—leprosy	0.0364	0.0388	CbGbCtD
Nelfinavir—CYP1A2—Thalidomide—leprosy	0.0347	0.037	CbGbCtD
Nelfinavir—CYP1A2—Rifampicin—leprosy	0.0336	0.0358	CbGbCtD
Nelfinavir—CYP2C9—Thalidomide—leprosy	0.0313	0.0333	CbGbCtD
Nelfinavir—CYP2C9—Rifampicin—leprosy	0.0303	0.0323	CbGbCtD
Nelfinavir—CYP2C19—Dapsone—leprosy	0.0301	0.0321	CbGbCtD
Nelfinavir—ABCB1—Rifampicin—leprosy	0.0294	0.0313	CbGbCtD
Nelfinavir—CYP2C9—Dapsone—leprosy	0.025	0.0267	CbGbCtD
Nelfinavir—CYP3A4—Rifampicin—leprosy	0.0176	0.0188	CbGbCtD
Nelfinavir—CYP3A4—Dapsone—leprosy	0.0145	0.0155	CbGbCtD
Nelfinavir—Fungal skin infection—Thalidomide—leprosy	0.00266	0.0426	CcSEcCtD
Nelfinavir—Sexual dysfunction—Thalidomide—leprosy	0.00198	0.0317	CcSEcCtD
Nelfinavir—Myasthenia—Thalidomide—leprosy	0.00177	0.0283	CcSEcCtD
Nelfinavir—Hyperlipidaemia—Thalidomide—leprosy	0.00154	0.0247	CcSEcCtD
Nelfinavir—Muscular weakness—Dapsone—leprosy	0.00139	0.0223	CcSEcCtD
Nelfinavir—Pancreatitis—Dapsone—leprosy	0.00133	0.0214	CcSEcCtD
Nelfinavir—Accidental injury—Thalidomide—leprosy	0.00125	0.0201	CcSEcCtD
Nelfinavir—Hyperbilirubinaemia—Thalidomide—leprosy	0.00122	0.0196	CcSEcCtD
Nelfinavir—Hyperuricaemia—Thalidomide—leprosy	0.0012	0.0192	CcSEcCtD
Nelfinavir—Sinusitis—Dapsone—leprosy	0.00114	0.0182	CcSEcCtD
Nelfinavir—Blood uric acid increased—Thalidomide—leprosy	0.00113	0.0181	CcSEcCtD
Nelfinavir—Pharyngitis—Dapsone—leprosy	0.00108	0.0173	CcSEcCtD
Nelfinavir—Rash maculo-papular—Thalidomide—leprosy	0.00101	0.0162	CcSEcCtD
Nelfinavir—Hyperkinesia—Thalidomide—leprosy	0.000968	0.0155	CcSEcCtD
Nelfinavir—Erythema—Dapsone—leprosy	0.000948	0.0152	CcSEcCtD
Nelfinavir—Diabetes mellitus—Thalidomide—leprosy	0.000926	0.0149	CcSEcCtD
Nelfinavir—Injury—Thalidomide—leprosy	0.000877	0.0141	CcSEcCtD
Nelfinavir—Dermatitis bullous—Thalidomide—leprosy	0.000843	0.0135	CcSEcCtD
Nelfinavir—Arthritis—Thalidomide—leprosy	0.000829	0.0133	CcSEcCtD
Nelfinavir—Hypoglycaemia—Thalidomide—leprosy	0.000826	0.0132	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000806	0.0129	CcSEcCtD
Nelfinavir—Affect lability—Thalidomide—leprosy	0.000793	0.0127	CcSEcCtD
Nelfinavir—Migraine—Thalidomide—leprosy	0.000793	0.0127	CcSEcCtD
Nelfinavir—Mood swings—Thalidomide—leprosy	0.000763	0.0122	CcSEcCtD
Nelfinavir—Dehydration—Thalidomide—leprosy	0.000749	0.012	CcSEcCtD
Nelfinavir—Liver function test abnormal—Thalidomide—leprosy	0.000744	0.0119	CcSEcCtD
Nelfinavir—Cramp muscle—Thalidomide—leprosy	0.000726	0.0116	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000726	0.0116	CcSEcCtD
Nelfinavir—Muscular weakness—Thalidomide—leprosy	0.000711	0.0114	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Thalidomide—leprosy	0.000711	0.0114	CcSEcCtD
Nelfinavir—Abdominal distension—Thalidomide—leprosy	0.000701	0.0112	CcSEcCtD
Nelfinavir—Insomnia—Dapsone—leprosy	0.0007	0.0112	CcSEcCtD
Nelfinavir—Bronchospasm—Thalidomide—leprosy	0.000685	0.011	CcSEcCtD
Nelfinavir—Pancreatitis—Thalidomide—leprosy	0.000683	0.0109	CcSEcCtD
Nelfinavir—Neutropenia—Thalidomide—leprosy	0.000651	0.0104	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Dapsone—leprosy	0.000633	0.0101	CcSEcCtD
Nelfinavir—Hyperglycaemia—Thalidomide—leprosy	0.000628	0.0101	CcSEcCtD
Nelfinavir—Pneumonia—Thalidomide—leprosy	0.000625	0.01	CcSEcCtD
Nelfinavir—Abdominal pain—Dapsone—leprosy	0.000612	0.0098	CcSEcCtD
Nelfinavir—Body temperature increased—Dapsone—leprosy	0.000612	0.0098	CcSEcCtD
Nelfinavir—Stomatitis—Thalidomide—leprosy	0.000605	0.0097	CcSEcCtD
Nelfinavir—Sweating—Thalidomide—leprosy	0.000595	0.00954	CcSEcCtD
Nelfinavir—Epistaxis—Thalidomide—leprosy	0.000586	0.00939	CcSEcCtD
Nelfinavir—Sinusitis—Thalidomide—leprosy	0.000583	0.00934	CcSEcCtD
Nelfinavir—Rhinitis—Thalidomide—leprosy	0.000559	0.00896	CcSEcCtD
Nelfinavir—Hepatitis—Thalidomide—leprosy	0.000557	0.00894	CcSEcCtD
Nelfinavir—Pharyngitis—Thalidomide—leprosy	0.000553	0.00887	CcSEcCtD
Nelfinavir—Erythema multiforme—Thalidomide—leprosy	0.000527	0.00845	CcSEcCtD
Nelfinavir—Eye disorder—Thalidomide—leprosy	0.000521	0.00835	CcSEcCtD
Nelfinavir—Angiopathy—Thalidomide—leprosy	0.000506	0.00811	CcSEcCtD
Nelfinavir—Immune system disorder—Thalidomide—leprosy	0.000504	0.00807	CcSEcCtD
Nelfinavir—Vomiting—Dapsone—leprosy	0.000492	0.00789	CcSEcCtD
Nelfinavir—Malnutrition—Thalidomide—leprosy	0.000485	0.00778	CcSEcCtD
Nelfinavir—Headache—Dapsone—leprosy	0.000485	0.00777	CcSEcCtD
Nelfinavir—Flatulence—Thalidomide—leprosy	0.000478	0.00767	CcSEcCtD
Nelfinavir—Back pain—Thalidomide—leprosy	0.000469	0.00752	CcSEcCtD
Nelfinavir—Muscle spasms—Thalidomide—leprosy	0.000467	0.00748	CcSEcCtD
Nelfinavir—Nausea—Dapsone—leprosy	0.00046	0.00737	CcSEcCtD
Nelfinavir—Ill-defined disorder—Thalidomide—leprosy	0.00045	0.00722	CcSEcCtD
Nelfinavir—Anaemia—Thalidomide—leprosy	0.000449	0.00719	CcSEcCtD
Nelfinavir—Agitation—Thalidomide—leprosy	0.000446	0.00715	CcSEcCtD
Nelfinavir—Malaise—Thalidomide—leprosy	0.000438	0.00702	CcSEcCtD
Nelfinavir—Leukopenia—Thalidomide—leprosy	0.000434	0.00696	CcSEcCtD
Nelfinavir—Convulsion—Thalidomide—leprosy	0.00042	0.00674	CcSEcCtD
Nelfinavir—Myalgia—Thalidomide—leprosy	0.000413	0.00662	CcSEcCtD
Nelfinavir—Arthralgia—Thalidomide—leprosy	0.000413	0.00662	CcSEcCtD
Nelfinavir—Anxiety—Thalidomide—leprosy	0.000412	0.0066	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00041	0.00658	CcSEcCtD
Nelfinavir—Discomfort—Thalidomide—leprosy	0.000408	0.00654	CcSEcCtD
Nelfinavir—Oedema—Thalidomide—leprosy	0.000396	0.00635	CcSEcCtD
Nelfinavir—Thrombocytopenia—Thalidomide—leprosy	0.000388	0.00622	CcSEcCtD
Nelfinavir—Skin disorder—Thalidomide—leprosy	0.000385	0.00617	CcSEcCtD
Nelfinavir—Hyperhidrosis—Thalidomide—leprosy	0.000383	0.00614	CcSEcCtD
Nelfinavir—Anorexia—Thalidomide—leprosy	0.000378	0.00605	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Thalidomide—leprosy	0.000361	0.00578	CcSEcCtD
Nelfinavir—Insomnia—Thalidomide—leprosy	0.000358	0.00574	CcSEcCtD
Nelfinavir—Paraesthesia—Thalidomide—leprosy	0.000356	0.0057	CcSEcCtD
Nelfinavir—Dyspnoea—Thalidomide—leprosy	0.000353	0.00566	CcSEcCtD
Nelfinavir—Somnolence—Thalidomide—leprosy	0.000352	0.00564	CcSEcCtD
Nelfinavir—Dyspepsia—Thalidomide—leprosy	0.000349	0.00559	CcSEcCtD
Nelfinavir—Decreased appetite—Thalidomide—leprosy	0.000344	0.00552	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Thalidomide—leprosy	0.000342	0.00548	CcSEcCtD
Nelfinavir—Pain—Thalidomide—leprosy	0.000339	0.00543	CcSEcCtD
Nelfinavir—Feeling abnormal—Thalidomide—leprosy	0.000326	0.00523	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Thalidomide—leprosy	0.000324	0.00519	CcSEcCtD
Nelfinavir—Urticaria—Thalidomide—leprosy	0.000315	0.00504	CcSEcCtD
Nelfinavir—Abdominal pain—Thalidomide—leprosy	0.000313	0.00502	CcSEcCtD
Nelfinavir—Body temperature increased—Thalidomide—leprosy	0.000313	0.00502	CcSEcCtD
Nelfinavir—Hypersensitivity—Thalidomide—leprosy	0.000292	0.00468	CcSEcCtD
Nelfinavir—Asthenia—Thalidomide—leprosy	0.000284	0.00456	CcSEcCtD
Nelfinavir—Pruritus—Thalidomide—leprosy	0.00028	0.00449	CcSEcCtD
Nelfinavir—Diarrhoea—Thalidomide—leprosy	0.000271	0.00434	CcSEcCtD
Nelfinavir—Dizziness—Thalidomide—leprosy	0.000262	0.0042	CcSEcCtD
Nelfinavir—Vomiting—Thalidomide—leprosy	0.000252	0.00404	CcSEcCtD
Nelfinavir—Rash—Thalidomide—leprosy	0.00025	0.004	CcSEcCtD
Nelfinavir—Dermatitis—Thalidomide—leprosy	0.000249	0.004	CcSEcCtD
Nelfinavir—Headache—Thalidomide—leprosy	0.000248	0.00398	CcSEcCtD
Nelfinavir—Nausea—Thalidomide—leprosy	0.000235	0.00377	CcSEcCtD
